A detailed history of Q Global Advisors, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Q Global Advisors, LLC holds 219,459 shares of ASND stock, worth $27.3 Million. This represents 28.82% of its overall portfolio holdings.

Number of Shares
219,459
Previous 219,459 -0.0%
Holding current value
$27.3 Million
Previous $29.9 Million 9.48%
% of portfolio
28.82%
Previous 21.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$121.07 - $153.67 $7.94 Million - $10.1 Million
-65,541 Reduced 23.0%
219,459 $29.9 Million
Q3 2023

Nov 14, 2023

BUY
$86.5 - $103.97 $7.79 Million - $9.36 Million
90,000 Added 46.15%
285,000 $26.7 Million
Q2 2023

Aug 14, 2023

BUY
$69.96 - $97.84 $6.75 Million - $9.43 Million
96,429 Added 97.83%
195,000 $17.4 Million
Q1 2023

May 15, 2023

SELL
$104.9 - $126.78 $5.54 Million - $6.7 Million
-52,838 Reduced 34.9%
98,571 $10.6 Million
Q4 2022

Feb 14, 2023

BUY
$99.42 - $131.97 $616,404 - $818,214
6,200 Added 4.27%
151,409 $18.5 Million
Q3 2022

Nov 14, 2022

BUY
$84.03 - $110.23 $2.12 Million - $2.78 Million
25,209 Added 21.01%
145,209 $16.7 Million
Q2 2022

Aug 15, 2022

SELL
$78.08 - $117.61 $3.16 Million - $4.76 Million
-40,500 Reduced 25.23%
120,000 $11.2 Million
Q1 2022

May 16, 2022

BUY
$102.18 - $135.75 $4.56 Million - $6.06 Million
44,615 Added 38.5%
160,500 $18.8 Million
Q4 2021

Feb 15, 2022

BUY
$127.1 - $169.66 $6.25 Million - $8.34 Million
49,171 Added 73.7%
115,885 $15.6 Million
Q3 2021

Nov 16, 2021

BUY
$112.67 - $176.92 $1.91 Million - $3.01 Million
16,993 Added 34.18%
66,714 $10.6 Million
Q2 2021

Aug 17, 2021

BUY
$121.62 - $145.29 $2.76 Million - $3.29 Million
22,657 Added 83.72%
49,721 $6.54 Million
Q1 2021

May 17, 2021

BUY
$124.92 - $173.33 $484,814 - $672,693
3,881 Added 16.74%
27,064 $3.49 Million
Q4 2020

Feb 17, 2021

BUY
$151.2 - $182.76 $3.51 Million - $4.24 Million
23,183 New
23,183 $3.87 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $6.94B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Q Global Advisors, LLC Portfolio

Follow Q Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Q Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Q Global Advisors, LLC with notifications on news.